Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

Latest Post

June 11, 2019

Particulate Challenges

Particulates in injectable drug products continue to be an area of great interest in the industry. The main reason is the potential clinical effects on patients, which can range from emboli to inflammations to infections. There are a series of clinical risk factors that should be considered in evaluating and mitigating these challenges. These factors are route of administration, patient population, and particulate composition (i.e., number, size, and shape). All are critical inputs to understanding risk and determining corrective and preventative actions.
Fran DeGrazio

Fran DeGrazio

V.P. Technical Customer Service & Scientific Affairs

Previous Posts
Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

April 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

Compatibility issues Chart

March 07, 2019

Simplify the Journey™ - Integrated Solutions for Particles

Doug Hostetler

Doug Hostetler

Sr Manager, Integrated Solutions, Lab

Particle Testing

March 01, 2019

Achieving ″Zero″ Defects for Visible Particles in Injectables

Olga Laskina

Olga Laskina

Sr Tech Acct Spec, TCS, NA

Leur Lock Syringes

February 25, 2019

Particles in Intravitreal Injections - Part II

Susan Dounce

Susan Dounce

Principal SME, PFS CZ, TCS

Analytical Laboratory

February 22, 2019

West Analytical Services Introduces New Particle Testing Capabilities

Deirdre Swinden

Deirdre Swinden

Director, Marketing Communications

Two scientists in the lab

February 20, 2019

Particles in Intravitreal Injections - Part I

Susan Dounce

Susan Dounce, PhD

Principal SME, Pre-filled Syringes

Particle Analysis

February 15, 2019

Particle Size Analysis – To Trust or Not?

SokTiang Koh

Sok-Tiang Koh

Vice President, Scientific Affairs & Technical Services, Asia-Pacific

Survey Responses

January 25, 2019

Industry Insight – Particles and Sterile Drug Products

Verun Gupta

Varun Gupta

Supervisor, Particles, Analytical Labs NA

HSP of the lyophilized BSA powder determined by HSPIP software

January 16, 2018

Selecting the Right Package System – a New Approach

Page McAndrew

Page McAndrew

Director, Scientific Communications, SA and TS

NovaPure 1-3 mL and 1 mL plungers

September 28, 2017

Controlling Particle Load in NovaPure® Elastomer Components

Page McAndrew

Page McAndrew

Director, Scientific Communications, Scientific Affairs & TCS

Fran DeGrazio

July 18, 2017

USP Particle Workshop – Addressing Issues and Improving Clarity

Fran DeGrazio

Fran DeGrazio

Vice President, Scientific Affairs & Technical Services

Load more